Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience
- PMID: 21468175
- PMCID: PMC3064456
- DOI: 10.2147/VHRM.S17947
Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience
Abstract
Background and objectives: Cancer patients undergo routine imaging studies much more than others. The widespread use of the recently introduced multi-detector CT scanners has resulted in an increasing number of incidentally diagnosed pulmonary embolism (PE) in asymptomatic cancer patients. The significance and clinical outcome of such incidental PE is described.
Methods: Both radiology department and hospital databases were searched for all cancer patients with a diagnosis of incidental PE. CT scans were performed using a 64-slice scanner with a 5.0 mm slice thickness.
Results: During the study period, 34 patients with incidental PE were identified. The mean age (±SD) was 57.7 (±12.4) years. All patients had active cancer, gastric, lung, colorectal, and lymphomas being the most frequent. Most patients had advanced-stage disease at the time of PE diagnosis; 26 (77%) patients had stage IV, whereas only 3 patients had stages I or II disease. Twenty-seven (79%) patients had their PE while undergoing active treatment with chemotherapy (68%) or radiotherapy (12%); none, however, were on hormonal therapy. Most (74%) patients had their PE diagnosed without history of recent hospital admission. Except for 5 (15%), all other patients were anticoagulated. With follow-up, 2 patients developed recurrent PE, 2 others had clinical and echocardiographic evidence of pulmonary hypertension, and 9 (26%) died suddenly within 30 days of the diagnosis of incidental PE; 2 of these where among the 5 patients who were not anticoagulated.
Conclusion: Incidental PE in cancer patients is increasingly encountered. Similar to symptomatic PE, many were diagnosed in patients with advanced stage disease and while undergoing active anti-cancer therapy. A significant percentage of patients had recurrent emboli, pulmonary hypertension, and sudden death.
Keywords: cancer; chemotherapy; incidental; pulmonary embolism.
© 2011 Abdel-Razeq et al, publisher and licensee Dove Medical Press Ltd.
Similar articles
-
Management of incidental pulmonary embolism.Eur Respir J. 2017 Jun 29;49(6):1700275. doi: 10.1183/13993003.00275-2017. Print 2017 Jun. Eur Respir J. 2017. PMID: 28663318 Review.
-
Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging.J Thorac Oncol. 2010 Jun;5(6):798-803. doi: 10.1097/JTO.0b013e3181d6153a. J Thorac Oncol. 2010. PMID: 20421822
-
Outcome of incidentally diagnosed pulmonary embolism in patients with malignancy.Curr Opin Pulm Med. 2012 Sep;18(5):399-405. doi: 10.1097/MCP.0b013e3283553914. Curr Opin Pulm Med. 2012. PMID: 22634737 Review.
-
Pulmonary emboli after blunt trauma: timing, clinical characteristics and natural history.Injury. 2012 Sep;43(9):1502-6. doi: 10.1016/j.injury.2010.12.028. Epub 2011 Jun 30. Injury. 2012. PMID: 21722897
-
The clinician's response to a report of an incidental pulmonary embolism detected on multidetector CT.Postgrad Med J. 2011 Nov;87(1033):746-9. doi: 10.1136/pgmj.2011.118497. Epub 2011 Aug 27. Postgrad Med J. 2011. PMID: 21873651
Cited by
-
Incidental venous thromboembolic events in cancer patients: what we know in 2016.Thromb Res. 2016 Apr;140 Suppl 1(Suppl 1):S18-20. doi: 10.1016/S0049-3848(16)30093-7. Thromb Res. 2016. PMID: 27067973 Free PMC article. Review.
-
Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients.Drug Des Devel Ther. 2016 Aug 24;10:2677-9. doi: 10.2147/DDDT.S115852. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27601884 Free PMC article. No abstract available.
-
Incidental pulmonary embolism in oncology patients with current macroscopic malignancy: incidence in different tumour type and impact of delayed treatment on survival outcome.Br J Radiol. 2018 Jul;91(1088):20170806. doi: 10.1259/bjr.20170806. Epub 2018 May 10. Br J Radiol. 2018. PMID: 29688026 Free PMC article.
-
Clinical analysis of tumor and non-tumor patients complicated with pulmonary embolism.Int J Clin Exp Med. 2015 Oct 15;8(10):18729-36. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770488 Free PMC article.
-
Correlating Patient Symptoms and CT Morphology in AI-Detected Incidental Pulmonary Embolisms.Diagnostics (Basel). 2025 Jun 27;15(13):1639. doi: 10.3390/diagnostics15131639. Diagnostics (Basel). 2025. PMID: 40647638 Free PMC article.
References
-
- Kniffin WD, Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA., Jr The epidemiology of pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994;154:861–866. - PubMed
-
- Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ., 3rd Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case–control study. Arch Intern Med. 2000;160:809–815. - PubMed
-
- Heit JA, O’Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162:1245–1248. - PubMed
-
- Thodiyil PA, Kakkar AK. Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost. 2002;87:1076–1077. - PubMed
-
- Ryu JH, Olson EJ, Pellikka PA. Clinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic cases. Mayo Clin Proc. 1998;73:873–879. - PubMed